Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05319652
Other study ID # 2022-6312
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 6, 2022
Est. completion date March 23, 2023

Study information

Verified date July 2023
Source CHU de Quebec-Universite Laval
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Based on a mixed-methods design, the objective of this trial is to assess the feasibility and acceptability of the "Agir pour moi" program, an 8-week online self-management program for chronic non-cancer pain (CNCP). The investigators will also explore its potential effects on self-efficacy, pain interference, pain severity, anxiety, depression, catastrophizing, and global impression of change in adults with CNCP awaiting services from a chronic pain multidisciplinary treatment center.


Description:

The mixed-methods sequential explanatory design combines a quantitative questionnaire-based study with a subsequent in depth qualitative approach.


Recruitment information / eligibility

Status Completed
Enrollment 63
Est. completion date March 23, 2023
Est. primary completion date March 23, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years; - live with CNCP for more than 3 months; - read and understand French easily; - have access to a computer and high-speed Internet; - be available to take part in the project for 6 to 8 months; - not having started a new treatment for pain within the last month; - agree to notify the team before starting a new treatment; - be able to give informed consent. Exclusion Criteria: - be supported by a multidisciplinary treatment center or be likely to be in the short term; - having participated in a CNCP self-management program within the last year; - be awaiting scheduled surgical treatment within six months.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Pain self-management program
Each week for eight weeks, participants are invited to complete self-directed lessons on particular themes. The program covers goal setting, stress management through relaxation, breathing and mindfulness, pacing, physical activity, thoughts and emotions, sleep, nutrition, flare-up management, and planning. Through pain education, positive testimonials from individuals with CNCP applying the suggested strategies, reflective activities, goal setting and monitoring, and the gradual development of a personal plan, the program supports self-efficacy building to manage CNCP.

Locations

Country Name City State
Canada CHU de Québec Québec Quebec

Sponsors (1)

Lead Sponsor Collaborator
CHU de Quebec-Universite Laval

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of the recruitment Number of potentially eligible adults referred by the multidisciplinary treatment center over the recruitment period
Number of referred adults who respond to the invitation
Number of referred adults who consent to participate in the study
Number of interested adults excluded based on inclusion/exclusion criteria
Baseline
Primary Feasibility of data collection Rate of response to the questionnaires
Rate of completed questionnaires (no missing data)
Baseline
Primary Feasibility of data collection Rate of response to the questionnaires
Rate of completed questionnaires (no missing data)
Post-intervention (8 weeks)
Primary Feasibility of data collection Rate of response to the questionnaires
Rate of completed questionnaires (no missing data)
3 months post-intervention
Primary Acceptability The Acceptability E-scale includes 6 items regarding how easy and enjoyable the program was to use, how understandable were the lessons, how helpful was completing the program, whether the participant liked the program, whether the amount of time to complete the program was acceptable, and overall satisfaction with the program. Scores can range from 6 to 30. Higher scores reprensent a high level of acceptability. Post-intervention (8 Weeks)
Primary Acceptability Qualitative data from semi-structured interviews 4 months post-intervention
Primary Adherence to the program Completion rate of the program (completion is following = 75% of the lessons) Post-intervention (8 weeks)
Secondary Change in self-efficacy: French version of the Pain Self-Efficacy Questionnaire (PSEQ) The PSEQ is a ten item questionnaire which assesses an individual's confidence in their ability to perform a variety of activities or tasks despite pain. Scores can range from 0 to 60. Higher scores represent lower confidence to function with pain. Baseline; Post-intervention (8 weeks); 3 months post-intervention
Secondary Change in pain severity and pain interference: French version of the Brief Pain Inventory (BPI) The BPI includes a pain severity subscale and a pain interference subscale. The pain interference subscale measures the extent to which pain interferes with functions such as general activity, walking ability, normal work, mood, relationships with people, enjoyment of life and sleep. For each scale, the total score is the average of all items. Scores can range from 0 to 10 for each subscale. Higher scores indicate greater severity and more interference. Baseline; Post-intervention (8 weeks); 3 months post-intervention
Secondary Change in anxiety and depression: French version of the Hospital Anxiety and Depression Scale (HADS) The HADS is a 14-item scale. Seven items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale. Baseline; Post-intervention (8 weeks); 3 months post-intervention
Secondary Change in pain catastrophizing: French version of the Pain Catastrophizing Scale (PCS) The PCS is a 13-item questionnaire designed to assess catastrophic thinking in relation to pain. It yields a total score and three subscale scores assessing rumination, magnification and helplessness. Scores can range from 0 to 52. Higher scores represent higher pain catastrophizing. Baseline; Post-intervention (8 weeks); 3 months post-intervention
Secondary Patient Global Impression of Change Scale (PGIC) The PGIC measures a patient's rating of overall improvement or lack thereof due to the intervention. It is a 7 point scale depicting a patient's rating of overall improvement. Patients rate their change as "very much improved," "much improved," "minimally improved," "no change," "minimally worse," "much worse," or "very much worse." Post-intervention (8 weeks); 3 months post-intervention
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain